New stent study aims to improve heart outcomes for all, especially diabetics
NCT ID NCT04475380
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how well the Xience Sierra drug-coated stent works in a broad group of heart disease patients, including those with diabetes or prediabetes. Over 1,700 participants received the stent during a routine procedure to open blocked arteries. Researchers tracked heart-related events like death, heart attack, or need for repeat procedures for up to two years to see if the stent is safe and effective in real-world, high-risk patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Xience Sierra everolimus-eluting stent
What this could lead to
If successful, this could confirm that the Xience Sierra stent is safe and effective for a wide range of heart disease patients, including those with diabetes.
What could go wrong
This is a completed observational study, not a randomized trial, so results may not prove superiority over other stents. Risks include typical stent complications like blood clots or re-narrowing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Haga Ziekenhuis
The Hague, Netherlands
-
Thoraxcentrum Twente
Enschede, Netherlands